C
Christopher A. Willoughby
Researcher at Merck & Co.
Publications - 22
Citations - 891
Christopher A. Willoughby is an academic researcher from Merck & Co.. The author has contributed to research in topics: Glycogen phosphorylase & Pyrrolidine. The author has an hindex of 16, co-authored 22 publications receiving 870 citations. Previous affiliations of Christopher A. Willoughby include Massachusetts Institute of Technology.
Papers
More filters
Patent
Pyrrolidine modulators of chemokine receptor activity
Charles G. Caldwell,Kevin T. Chapman,Jeffrey J. Hale,Dooseop Kim,Christopher L. Lynch,Malcolm MacCoss,Sander G. Mills,Keith G. Rosauer,Christopher A. Willoughby,Scott C. Berk +9 more
TL;DR: In this article, pyrrolidine compounds of formula (I) wherein R?1, R2, R3, R4, R5, R6? and n are defined herein) which are useful as modulators of chemokine receptor activity are presented.
Patent
Pyrrolidine and piperidine modulators of chemokine receptor activity
Richard J. Budhu,Jeffrey J. Hale,Edward Holson,Christopher L. Lynch,Malcolm MacCoss,Sander G. Mills,Scott C. Berk,Christopher A. Willoughby +7 more
TL;DR: In this paper, pyrrolidine and piperidine compounds of formula (I) were used as modulators of the chemokine receptors CCR-1, CR-2, CRCR-2A, CRC-2B, CRCS-3, CCRCS-4, CCS-5, CXCR-3 and/or CXCSCR-4.
Journal ArticleDOI
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
Jennifer Rotonda,Margarita Garcia-Calvo,Herb G. Bull,Wayne M. Geissler,Brian M. McKeever,Christopher A. Willoughby,Nancy A. Thornberry,Joseph W. Becker +7 more
TL;DR: Differences account for the variation in substrate specificity among granzyme B, other serine proteases and the caspases, and enable the design of specific inhibitors that can probe the physiological functions of these proteins and the disease states with which they are associated.
Journal ArticleDOI
Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.
Christopher A. Willoughby,Herbert G. Bull,Margarita Garcia-Calvo,Joanne Jiang,Kevin T. Chapman,Nancy A. Thornberry +5 more
TL;DR: A novel class of small molecule human granzyme B inhibitors is reported that blocks CTL mediated apoptosis with an IC(50) of 3 micromolar and has a K(i) of 7 nM against human gran enzyme B.
Journal ArticleDOI
Solid phase synthesis of aryl amines
TL;DR: In this article, a palladium mediated coupling reaction between aryl bromides and amines was used for the solid phase synthesis of amines, resulting in high purity and good yields.